Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Overexpression of MMP9 in colonic epithelium mediates protection in colitis associated cancer PALLAVI GARG Ph.D. Disclosures Nothing to Disclose Matrix Metalloproteinases (MMPs) Are a family of zinc-dependent proteolytic enzymes with the ability to degrade extracellular matrix substrates such as collagen, gelatin and proteoglycans Colitis Associated Cancer (CAC) & Colorectal Cancer • • • • • CAC is an important complication of Ulcerative Colitis or colonic Crohn’s Disease that results in significant morbidity and mortality It causes 1/6 of all deaths in patients with ulcerative colitis Colon cancer develops in flat dysplastic tissue among IBD individuals CAC is often multiple, anaplastic, broadly infiltrating, rapidly growing and occurs at a younger age The pathogenesis of CAC is not known MMP9 and its role in acute colitis • • MMP9 is not expressed in normal tissues and is one of the predominant MMPs that is up-regulated in several animal models of colitis and human IBD MMP9 mRNA and protein levels are increased in the inflamed colonic mucosa of patients with IBD • MMP9 activity correlates with active inflammation • MMP9 activates Notch1 signaling in colonic epithelium Castaneda et al, 2005, Gastroenterology Garg et al, 2007, Gastroenterology Role of MMP9 in CAC • MMP9-/- mice show increased susceptibility to CAC • CAC in MMP9-/- mice is associated with decreased apoptosis compared to WT mice • CAC in MMP9-/- mice showed decreased levels of p21WAF1/Cip1 and p53 • MMP9 mediates its tumor suppressive role via activation of Notch1 signaling Garg et al, 2010, Cancer Research Garg et al, 2011, Gastroenterology Aim Which MMP9 protects from CAC ? In vivo model C57/B6 WT Water DSS (3 cycles) Tg-villin-MMP9 Water DSS= Dextran Sodium Sulfate (3% in drinking water) DSS (3 cycles) In vivo protocol Days 0 7 14 28 35 49 53 DSS Cycle DSS Cycle DSS Cycle (3rd ) starts (1st) starts (2nd ) starts Recovery Recovery Recovery st (1 ) starts (2nd) starts (3rd) starts 85 sacrifice Body weight gain in percentage Overexpression of epithelial MMP9 exhibited resistance to CAC * * * 1 2 * 3 Tg-villin-MMP9 WT Sacrifice DSS DSS DSS cycle 2 cycle 3 cycle 1 Recovery Recovery Recovery cycle 2 cycle 3 cycle 1 Overexpression of epithelial MMP9 exhibited less tumor incidence in CAC B Number of polyps Number of dysplastic lesions A WT CAC Tg-villin-MMP9 CAC * WT CAC Tg-villin-MMP9 CAC Overexpression of epithelial MMP9 exhibited resistance to CAC X10 WT CAC Tg-villinMMP9 CAC X20 Overexpression of epithelial MMP9 showed increased levels of Notch1and p53 in CAC A Tg-villinMMP9, CAC WT, CAC MMP9, 104 kD β-tubulin 1 2 3 4 5 6 Tg-villinMMP9, CAC WT, CAC B NICD, 80 kD β-tubulin 1 2 3 4 5 6 Tg-villinMMP9, CAC WT, CAC C p53, 53 kD GAPDH 1 2 3 4 5 6 Overexpression of epithelial MMP9 showed increased levels of p21WAF1/Cip1and Bax1 in CAC A Tg-villinMMP9, CAC WT, CAC p21WAF1/Cip1, 21kD GAPDH 1 B 2 3 4 5 6 Tg-villinWT, CAC MMP9, CAC Bax-1, 37 kD GAPDH 1 2 3 4 5 6 Overexpression of MMP9 in MMP9-/- MEFs showed increased levels of Notch1 and p53 MMP9-/MEFs WT MEFs MMP9-/-MEFs + MMP9 A MMP-9, 104 kD B NICD, 80 kD GAPDH 1 2 MMP9-/MEFs 3 4 5 WT MEFs 6 MMP9-/-MEFs + MMP9 C p53, 53 kD GAPDH 1 2 3 4 5 6 Summary •Epithelial-derived MMP9 plays a tumor suppressive role in CAC • Overexpression of MMP9 in colonic epithelium is associated with altered levels of p53, Notch1, Bax1 and p21WAF1/Cip1 • Overexpression of MMP9 in MMP9 of NICD and p53 -/-exhibited increased levels Molecular mechanism of p53 regulation by MMP9 via Notch1 Inflammation nucleus ARF + + + Mdm2 ARF Notch-1 Mdm2 Mdm2 + p53 cytosol + MMP-9 Conclusions • Despite being a mediator of acute inflammation, epithelial derived- MMP9 acts as a tumor suppressor in CAC • MMP9 mediated p53 activation via Notch1 signaling is necessary and sufficient for its tumor suppressive effect in CAC Acknowledgement Didier Merlin Lewins Walter Crohn’s & Colitis Foundation of America Career Development Award, (#3057)